Essential Reads: Is PMDD a Risk Factor for Postpartum Depression?
Some, but not all, studies suggest that PMDD is a risk factor for postpartum depression.
Some, but not all, studies suggest that PMDD is a risk factor for postpartum depression.
Lamotrigine is detected in the breast milk and in the serum of the nursing infant; however, the risk of adverse events is very low.
Although most women transition to menopause without experiencing psychiatric problems, an estimated 20% experience depression at some point during the menopausal transition.
This review discusses the novel neurosteroid antidepressant brexanolone for the treatment of postpartum depression.
This clinical cohort study showed no impact of prenatal lithium exposure on cognitive functioning in children 6 to 14 years of age.
In a webinar put together by 2020 Mom, presenters provide an overview of maternal suicide, review risk factors for suicide in this population, and discuss efforts to generate accurate data on maternal suicide.
In a recent article, Margaret Spinelli, MD describes a proposal to the DSM-V committee of the American Psychiatric Association in 2020 arguing for the inclusion of postpartum psychosis as a unique diagnosis...
Neuroactive steroids, derivatives of allopregnanolone, may be effective for the treatment of premenstrual dysphoric disorder.
Given limited data on the reproductive safety of oxcarbazepine, we would recommend using alternate medications during pregnancy, when possible.Â
In terms of the efficacy of bright light therapy for depression during pregnancy, the jury is still out.Â